Table 2.
Treatment group |
Placebo | |||
---|---|---|---|---|
0.1 mg NBI-6024 | 0.5 mg NBI-6024 | 1.0 mg NBI-6024 | ||
Baseline | 47 | 48 | 43 | 44 |
134 ± 63 | 131 ± 62 | 135 ± 57 | 134 ± 59 | |
Month 24 | 42 | 46 | 37 | 40 |
57 ± 71 | 53 ± 56 | 44 ± 55 | 50 ± 45 | |
P | 0.5 | 0.6 | 0.9 |
Data are n or means ± SD (pmol × min/ml).